Target intelligence / Profile preview

Coordinated Lysosomal Expression and Regulation (CLEAR) motif-containing DNA promoters (CLEAR network promoters)

Target
CLEAR network promoters
Molecular classification
DNA regulatory element, Promoter, Non-coding DNA
01

Overview

The Coordinated Lysosomal Expression and Regulation (CLEAR) motif-containing DNA promoters represent a gene network essential for maintaining cellular proteostasis and metabolic health. These promoters contain a conserved 10-base pair sequence (GTCACGTGAC) that serves as the primary binding site for the Transcription Factor EB (TFEB) and other members of the MiT/TFE family (Sardiello et al., 2009). Upon activation, TFEB translocates to the nucleus and binds to these CLEAR motifs to coordinately upregulate genes involved in lysosomal biogenesis, autophagy, and lipid catabolism (Settembre et al., 2011). This regulatory network is a critical therapeutic target for neurodegenerative diseases, such as Alzheimer's and Parkinson's, where enhancing the clearance of misfolded protein aggregates is beneficial (Napolitano & Ballabio, 2016). Conversely, in certain cancers, the CLEAR network is often constitutively active, providing nutrients to tumor cells and promoting survival under stress, which suggests that inhibition may be a viable strategy in oncology (Perera et al., 2015). Current pharmacological approaches focus on small molecules like trehalose or mTOR inhibitors that indirectly modulate the CLEAR network by promoting TFEB nuclear entry (Palmieri et al., 2011).

Other names
CLEAR elementsCLEAR motifsTFEB-binding sitesCoordinated Lysosomal Expression and Regulation network
02

Mechanism of action

Modulation of transcription factor activity (primarily TFEB) to regulate the expression of the CLEAR gene network.

03

Biological functions

AutophagyLysosomal biogenesisLipid metabolismProteostasisCellular homeostasis
04

Disease associations

Neurodegenerative diseaseLysosomal storage disorderCancerMetabolic disorder
05

Safety considerations

Pro-survival role in established tumorsPotential for systemic over-activation of degradative pathwaysOff-target effects of TFEB modulators
06

Interacting drugs

Torin 1

7 more in the full profile.

07

Biomarkers

TFEB nuclear translocationLAMP1 expressionLC3-II levelsCathepsin D activityLysosomal pH

Beyond the preview

Go deeper on Coordinated Lysosomal Expression and Regulation (CLEAR) motif-containing DNA promoters (CLEAR network promoters).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coordinated Lysosomal Expression and Regulation (CLEAR) motif-containing DNA promoters (CLEAR network promoters).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call